The ADDF offers funding to researchers in both nonprofit and for-profit organizations for Alzheimer's drug discovery and preclinical development, clinical trials, and biomarker development research. Visit our Research Priorities for specific information about our interests.
Our funding is open to:
• Researchers, clinicians, and postdoctoral fellows
• Working in academia and biotechnology companies
• Based in the U.S. and worldwide
The ADDF currently accepts grant proposals through the following RFPs. For returning grantees, we accept proposals for follow-on funding and renewals.
ADDF FUNDING PORTAL
We provide applicants with a streamlined review process—the average time from letter of intent (LOI) decision to award decision is less than four months. For most RFPs, letters of intent are accepted and reviewed on a rolling basis during four cycles each year, corresponding to our four invited full proposal reviews.
CORE REQUESTS FOR PROPOSALS
WE ARE NOT ACCEPTING NEW LOIs FOR CORE RFPs AT THIS TIME.
Please check back on December 11, 2017 for the new Core RFPs and deadlines for 2018.
Program to Accelerate Clinical Trials (PACT) RFP
Seeks to fund Phase 1 safety testing, Phase 2 biomarker-based, proof-of-concept pilot clinical trials, and IND-enabling studies.
Biomarkers Development RFP
Seeks to support the development and validation of novel and existing biomarkers that will enhance the design and performance of clinical trials for Alzheimer's disease, related dementias, and cognitive aging.
Prevention Beyond the Pipeline RFP
Seeks to support comparative effectiveness research, clinical trials, and epidemiological studies that probe whether the use or choice of drugs alters the risk for dementia or cognitive decline.
Preclinical Drug Discovery RFP
Seeks to fund promising preclinical drug discovery for Alzheimer's disease, related dementias, and cognitive aging.
OTHER ADDF FUNDING OPPORTUNITIES
Supports NIA and NINDS grant proposals in NIH format that were scored but not funded, which fall within our mission and research priorities.
Supports scientific conferences that are relevant to our mission with grants up to $10,000. For more information, email firstname.lastname@example.org with a brief summary of your conference